Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

NIKOLIC, Dragana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.615
EU - Europa 3.073
AS - Asia 2.534
SA - Sud America 495
AF - Africa 74
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.545
IT - Italia 947
SG - Singapore 918
RU - Federazione Russa 829
CN - Cina 693
BR - Brasile 396
FI - Finlandia 278
VN - Vietnam 257
HK - Hong Kong 248
PL - Polonia 178
GB - Regno Unito 153
DE - Germania 147
FR - Francia 137
IE - Irlanda 135
JP - Giappone 82
IN - India 66
UA - Ucraina 59
KR - Corea 55
SE - Svezia 41
NL - Olanda 39
RO - Romania 36
BD - Bangladesh 35
AR - Argentina 30
MX - Messico 28
CA - Canada 26
TR - Turchia 22
IQ - Iraq 20
AT - Austria 19
CI - Costa d'Avorio 18
UZ - Uzbekistan 17
IR - Iran 15
ZA - Sudafrica 15
PY - Paraguay 14
BE - Belgio 13
MY - Malesia 13
CO - Colombia 12
ES - Italia 12
CL - Cile 11
ID - Indonesia 11
PK - Pakistan 11
AU - Australia 10
CZ - Repubblica Ceca 10
KE - Kenya 10
MA - Marocco 10
NP - Nepal 10
VE - Venezuela 10
EC - Ecuador 9
PH - Filippine 9
SA - Arabia Saudita 8
CH - Svizzera 7
GR - Grecia 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BG - Bulgaria 5
DK - Danimarca 5
HN - Honduras 5
IL - Israele 5
JO - Giordania 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
TN - Tunisia 4
AZ - Azerbaigian 3
EG - Egitto 3
NZ - Nuova Zelanda 3
PE - Perù 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AO - Angola 2
BH - Bahrain 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
HR - Croazia 2
JM - Giamaica 2
MD - Moldavia 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
BB - Barbados 1
BW - Botswana 1
CR - Costa Rica 1
CV - Capo Verde 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LY - Libia 1
MC - Monaco 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
Totale 12.807
Salva come PNG Salva come JPEG
Città #
Fairfield 966
Ashburn 767
Singapore 609
Woodbridge 413
Chandler 386
Seattle 376
Houston 368
Wilmington 363
Cambridge 333
San Jose 259
Hong Kong 238
Ann Arbor 192
Palermo 175
Zgierz 159
Moscow 149
Dublin 135
Beijing 128
Medford 118
Des Moines 99
Altamura 93
Santa Clara 89
Ho Chi Minh City 85
Los Angeles 79
Helsinki 77
Dallas 76
Tokyo 76
Council Bluffs 75
Princeton 75
Lauterbourg 68
Lawrence 68
Nanjing 67
New York 67
Hanoi 52
Rome 51
San Diego 51
Dearborn 39
Frankfurt am Main 39
São Paulo 39
Chicago 38
Milan 36
Changsha 33
Jinan 32
London 32
Boardman 31
Nanchang 31
The Dalles 30
Buffalo 28
Columbus 27
Hebei 27
Shenyang 27
Jacksonville 25
Nuremberg 24
Hefei 23
Tianjin 23
Orem 19
Phoenix 19
Abidjan 18
Tulsa 18
Zhengzhou 17
Amsterdam 14
Ludwigshafen am Rhein 14
Ningbo 14
Pune 14
Haiphong 13
Jiaxing 13
Munich 13
Naples 13
Rio de Janeiro 13
Turin 13
Guangzhou 12
Bologna 11
Boston 11
Brussels 11
Da Nang 11
Redwood City 11
San Paolo di Civitate 11
Taizhou 11
Tashkent 11
Vienna 11
Warsaw 11
Atlanta 10
Baghdad 10
Brno 10
Falls Church 10
Florence 10
Napoli 10
Paris 10
Saint Petersburg 10
Tehran 10
Belo Horizonte 9
Montreal 9
Nairobi 9
San Francisco 9
Asunción 8
Auburn Hills 8
Bangalore 8
Denver 8
Johannesburg 8
Manchester 8
Parma 8
Totale 8.495
Salva come PNG Salva come JPEG
Nome #
LE VESCICOLE EXTRACELLULARI VEGETALI PER LO SVILUPPO DI NUOVI NUTRACEUTICI: STUDIO PRE-CLINICO E CLINICO DELLE PROPRIETÀ BIOLOGICHE DELLE VESCICOLE ISOLATE DA SUCCO DI LIMONE 435
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 301
The dissociation of the Hsp60/pro-Caspase-3 complex by bis(pyridyl)oxadiazole copper complex (CubipyOXA) leads to cell death in NCI-H292 cancer cells 275
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 251
The Role of Nutraceuticals in Statin Intolerant Patients 243
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 241
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 230
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 226
A novel copper compound, CuNV110, induces apoptosis in tumor cells by dissociation of the Hsp60-pro-caspase 3 complex 221
Serum low density lipoprotein subclasses in asthma 220
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 219
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 217
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 214
Management of Statin Intolerance in 2018: Still More Questions Than Answers 211
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 210
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 201
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 197
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 197
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. 194
Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases 193
The effect of bergamot on dyslipidemia 190
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 185
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 184
Anti-cytokine therapy for prevention of atherosclerosis 183
Emerging approaches for the treatment of hypertriglyceridemia. 182
Should low high-density lipoprotein cholesterol (HDL-C) be treated? 180
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel 178
Effects of aging and diet on cardioprotection and cardiometabolic risk markers 177
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 173
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy 173
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. 172
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease 172
Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome 172
An evaluation of RVX-208 for the treatment of atherosclerosis 170
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 168
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel 168
Anti-inflammatory properties of an aldehydes-enriched fraction of grapefruit essential oil 166
Uric acid metabolism in pre-hypertension and the metabolic syndrome 165
CuNV1110 induces dissociation of the Hsp60-pro-caspase 3 complex and activation of apoptosis in tumor cells 164
Periodontitis, blood lipids and lipoproteins 164
Preliminary results of citraves™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study 164
The role of fibrate treatment in dyslipidemia: an overview. 163
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. 162
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 162
An overview of statin-induced myopathy and perspectives for the future 162
SUBFRACTIONS AND SUBPOPULATIONS OF HDL: AN UPDATE 162
Nutraceuticals as an important part of combination therapy in dyslipidaemia 157
Exosomal Heat Shock Proteins as a New Players in Tumor Cell-to-Cell Comunication 152
Effects of Liraglutide on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with The Metabolic Syndrome: A 12-Month Prospective Pilot Study 147
INCRETIN-BASED THERAPIES, GLUCOMETABOLIC HEALTH AND ENDOVASCULAR INFLAMMATION 145
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 144
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 143
Serum lipoproteins are not associated with the severity of asthma 143
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 142
Serological, immunomorphological and bioinformatics analyses suggest Hsp60 is involved in Hashimoto’s thyroiditis pathogenesis. 137
STATINS AND NEW-ONSET DIABETES 136
Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins Be Key Mediators Of This Association? 135
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 132
Incretins, pregnancy, and gestational diabetes 127
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children 126
Natural approaches in metabolic syndrome management 125
Intensive LDL-cholesterol lowering therapy and neurocognitive function 125
A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study) 120
Statin treatment in the elderly: how much do we know? 118
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 112
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors 112
Peroxisome proliferator-activated receptors and atherosclerosis 110
Gut microbiota, obesity and bariatric surgery: Current knowledge and future perspectives 108
Lifestyle recommendations for the prevention and management of metabolic syndrome: An international panel recommendation 106
PPAR agonists, atherogenic dyslipidemia and cardiovascular risk 103
Nutraceuticals as lipid-lowering treatment in pregnancy and their effects on the metabolic syndrome 101
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 98
IMPROVE-IT: What have we learned? 95
LIPOPROTEIN SUBCLASS DISTRIBUTION IN DIFFERENT CLINICAL PATTERNS AND THEIR VARIATION AFTER THERAPY 93
ETC-1002: A future option for lipid disorders? 91
Small, dense LDL: An update 90
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia 88
Psoriasis and acute coronary syndrome risk 79
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 77
null 61
Novel anti-obesity drugs and plasma lipids 55
Weight loss programmes using low carbohydrate diets to control the cardiovascular risk in adolescents (Review) 48
Totale 13.238
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 0 0 0 0 0 92 83
2021/2022946 96 135 32 23 22 63 28 72 104 160 45 166
2022/20231.296 142 253 21 121 130 187 112 104 138 12 55 21
2023/2024588 39 83 77 22 45 106 44 50 12 28 20 62
2024/20251.581 45 171 176 145 57 56 74 85 131 165 159 317
2025/20264.196 329 165 250 387 443 587 586 507 380 384 178 0
Totale 13.238